亞米克斯治療FOLD
那斯達克 · USD
10.88
+0.33
(+3.13%)
收盤 12/16 04:59 (UTC+8)
12/16 04:59 (UTC+8)
亞米克斯治療FOLD
10.88
+0.33
(+3.13%)
財務數據
損益表
- 0.95
- 1.04
- 1.15
- 1.10
- 1.27
- 1.42
- 1.50
- 1.25
- 1.55
- 1.69
- 9.54
- 9.52
- 11.19
- -4.07
- 14.73
- 11.72
- 5.79
- -16.34
- 23.50
- 9.29
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 169,061 | 154,688 | 125,249 | 149,706 | 141,517 | 126,669 | 110,403 | 115,082 | 103,501 | 94,503 |
營業成本 | 19,467 | 15,217 | 11,698 | 14,836 | 13,279 | 11,261 | 13,567 | 11,324 | 9,946 | 9,114 |
營業毛利 | 149,594 | 139,471 | 113,551 | 134,870 | 128,238 | 115,408 | 96,836 | 103,758 | 93,555 | 85,389 |
營業費用 | 115,325 | 148,945 | - | 118,899 | 106,579 | - | 124,557 | 107,450 | 110,578 | 104,249 |
研發費用 | 23,415 | 60,848 | 27,839 | 30,190 | 26,160 | 24,683 | 28,329 | 35,029 | 40,704 | 35,149 |
推銷及管理費用 | 90,036 | 84,543 | 91,827 | 86,668 | 75,106 | 73,576 | 88,029 | 70,239 | 67,646 | 65,760 |
非經常性項目費用 | - | 1,702 | - | - | 3,143 | - | 6,045 | - | - | 1,134 |
其他營業費用 | 1,874 | 1,852 | 1,837 | 2,041 | 2,170 | 2,182 | 2,154 | 2,182 | 2,228 | 2,206 |
營業利益 | 34,269 | -9,474 | -7,952 | 15,971 | 21,659 | 14,967 | -27,721 | -3,692 | -17,023 | -18,860 |
其他收入及費用 | 11,716 | 1,858 | 1,362 | 3,921 | -2,182 | -2,347 | -3,426 | -15,141 | 5,304 | -9,165 |
利息費用 | 11,711 | 11,565 | 11,455 | 11,958 | 12,692 | 12,512 | 12,436 | 12,827 | 12,986 | 12,492 |
稅前純益 | 34,274 | -19,181 | -18,045 | 7,934 | 6,785 | 108 | -43,583 | -31,660 | -24,705 | -40,517 |
所得稅 | 16,968 | 5,239 | 3,641 | -6,805 | 13,514 | 15,805 | 4,836 | 2,183 | -3,128 | 2,715 |
稅後純益 | 17,306 | -24,420 | -21,686 | 14,739 | -6,729 | -15,697 | -48,419 | -33,843 | -21,577 | -43,232 |
基本每股稅後盈餘(元) | 0.06 | -0.08 | -0.07 | 0.05 | -0.02 | -0.05 | -0.16 | - | -0.07 | -0.15 |
稀釋每股稅後盈餘(元) | 0.06 | -0.08 | -0.07 | 0.05 | -0.02 | -0.05 | -0.16 | -0.11 | -0.07 | -0.15 |
基本平均股數(千股) | 308468.00 | 308254.00 | 307689.00 | 306156.00 | 304690.00 | 303773.00 | 302903.00 | - | 295759.00 | 292797.00 |
稀釋平均股數(千股) | 310433.00 | 308254.00 | 307689.00 | 306156.00 | 304690.00 | 303773.00 | 302903.00 | - | 295759.00 | 292797.00 |
還原基本每股稅後盈餘(元) | 0.06 | -0.08 | -0.07 | 0.05 | -0.02 | -0.05 | -0.16 | - | -0.07 | -0.15 |
還原稀釋每股稅後盈餘(元) | 0.06 | -0.08 | -0.07 | 0.05 | -0.02 | -0.05 | -0.16 | -0.11 | -0.07 | -0.15 |
還原基本平均股數(千股) | 308,468 | 308,254 | 307,689 | 306,156 | 304,690 | 303,773 | 302,903 | - | 295,759 | 292,797 |
還原稀釋平均股數(千股) | 310,433 | 308,254 | 307,689 | 306,156 | 304,690 | 303,773 | 302,903 | - | 295,759 | 292,797 |
EBITDA(千元) | 48,517 | -5,134 | -4,147 | 22,530 | 22,221 | 15,362 | -28,462 | -16,115 | -8,770 | -25,127 |